Clinical trial
Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving…
NCT00057798 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00057798 |
|---|---|
| Title | Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery |
| Official title | Molecular And Genetic Changes In Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) Following Neoadjuvant Chemotherapy With Vinorelbine And Gemcitabine - Phase II Study |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Genetic, Procedure |
| Interventions | gemcitabine hydrochloride, vinorelbine ditartrate, cytogenetic analysis, loss of heterozygosity analysis, microarray analysis, conventional surgery, neoadjuvant therapy |
| Enrollment | 21 |
| Start date | Mar 1, 2000 |
| Primary completion | May 1, 2003 |
| Completion | Jun 1, 2008 |
| First posted | Apr 9, 2003 |
| Last update posted | Mar 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: